Italy
· Delayed Price · Currency is EUR Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of EUR 84.66 billion. The enterprise value is 105.01 billion.
| Market Cap | 84.66B |
| Enterprise Value | 105.01B |
Important Dates
The last earnings date was Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | Mar 7, 2025 |
Share Statistics
| Current Share Class | 225.93M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.07% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 225.44M |
Valuation Ratios
The trailing PE ratio is 15.47 and the forward PE ratio is 11.95.
| PE Ratio | 15.47 |
| Forward PE | 11.95 |
| PS Ratio | 0.50 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 42.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.65, with an EV/FCF ratio of 30.89.
| EV / Earnings | 19.18 |
| EV / Sales | 0.64 |
| EV / EBITDA | 11.65 |
| EV / EBIT | 12.78 |
| EV / FCF | 30.89 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.43 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.99 |
| Debt / FCF | 8.17 |
| Interest Coverage | 7.23 |
Financial Efficiency
Return on equity (ROE) is 14.17% and return on invested capital (ROIC) is 8.17%.
| Return on Equity (ROE) | 14.17% |
| Return on Assets (ROA) | 4.93% |
| Return on Invested Capital (ROIC) | 8.17% |
| Return on Capital Employed (ROCE) | 11.86% |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | 52,538 |
| Employee Count | 104,200 |
| Asset Turnover | 1.58 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -20.11% |
| 50-Day Moving Average | 383.37 |
| 200-Day Moving Average | 418.38 |
| Relative Strength Index (RSI) | 25.36 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.61 |
Income Statement
In the last 12 months, Elevance Health had revenue of EUR 169.43 billion and earned 5.47 billion in profits. Earnings per share was 23.69.
| Revenue | 169.43B |
| Gross Profit | 46.99B |
| Operating Income | 8.45B |
| Pretax Income | 7.18B |
| Net Income | 5.47B |
| EBITDA | 9.10B |
| EBIT | 8.45B |
| Earnings Per Share (EPS) | 23.69 |
Balance Sheet
The company has 31.13 billion in cash and 27.76 billion in debt, giving a net cash position of -20.82 billion.
| Cash & Cash Equivalents | 31.13B |
| Total Debt | 27.76B |
| Net Cash | -20.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 39.43B |
| Book Value Per Share | 174.28 |
| Working Capital | 17.04B |
Cash Flow
In the last 12 months, operating cash flow was 4.48 billion and capital expenditures -1.09 billion, giving a free cash flow of 3.40 billion.
| Operating Cash Flow | 4.48B |
| Capital Expenditures | -1.09B |
| Free Cash Flow | 3.40B |
| FCF Per Share | n/a |
Margins
Gross margin is 27.74%, with operating and profit margins of 4.99% and 3.23%.
| Gross Margin | 27.74% |
| Operating Margin | 4.99% |
| Pretax Margin | 4.24% |
| Profit Margin | 3.23% |
| EBITDA Margin | 5.37% |
| EBIT Margin | 4.99% |
| FCF Margin | 2.01% |
Dividends & Yields
This stock pays an annual dividend of 6.10, which amounts to a dividend yield of 1.53%.
| Dividend Per Share | 6.10 |
| Dividend Yield | 1.53% |
| Dividend Growth (YoY) | 8.34% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 25.60% |
| Buyback Yield | 2.07% |
| Shareholder Yield | 3.60% |
| Earnings Yield | 6.47% |
| FCF Yield | 4.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |